Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Published 31/01/2024, 18:18
© Reuters.  Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
AMD
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results.

AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion.

AMD shares dipped 3.8% to $165.49 on Wednesday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 204% to $0.6049. Connexa said it has regained compliance with Nasdaq minimum shareholder equity rule.
  • Minim, Inc. (NASDAQ: MINM) shares climbed 76.4% to $4.48. David E. Lazar disclosed a 51% active stake in Minim Inc.
  • Powell Industries, Inc. (NASDAQ: POWL) shares gained 49% to $121.89 after the company reported better-than-expected first-quarter financial results and raised its quarterly dividend.
  • Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) climbed 46.5% to $0.1180 after falling around 7% on Tuesday.
  • Ashford Hospitality Trust, Inc. (NYSE: AHT) jumped 32% to $1.77.
  • 2seventy bio, Inc. (NASDAQ: TSVT) rose 31.6% to $5.28. 2seventy Bio said it will focus exclusively on commercialization and development of Abecma and sell its R&D pipeline to Regeneron. Leerink Partners analyst Daina Graybosch upgraded 2seventy bio from Market Perform to Outperform and raised the price target from $5 to $18.
  • Trinity Biotech plc (NASDAQ: TRIB) gained 29.5% to $0.5638. Trinity Biotech announced acquisition of the CGM assets of Waveform Technologies, Inc.
  • Kuke Music Holding Limited (NYSE: KUKE) rose 23.7% to $1.25.
  • Vaxart, Inc. (NASDAQ: VXRT) jumped 20.9% to $1.1850. B. Riley Securities analyst Mayank Mamtani upgraded Vaxart from Neutral to Buy and announced a $2 price target.
  • Envirotech Vehicles, Inc. (NASDAQ: EVTV) gained 20.6% to $1.75.
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 19.6% to $1.7232. Ensysce Biosciences reported completion of a constructive end of Phase 2 meeting with the FDA regarding its lead 'next generation' analgesic, PF614.
  • Plug Power Inc. (NASDAQ: PLUG) climbed 17.8% to $4.3950 after Roth MKM upgraded the stock from Neutral to Buy and raised its price target from $4.5 to $9.
  • DocGo Inc. (NASDAQ: DCGO) gained 15.8% to $3.9497 after the company announced a share buyback program of up to $36 million.
  • Ashland Inc. (NYSE: ASH) jumped 14.5% to $92.50 after the company reported mixed first-quarter financial results and issued guidance.
  • Jin Medical International Ltd. (NASDAQ: ZJYL) rose 12.5% to $236.64.
  • LendingClub Corporation (NYSE: LC) gained 12.3% to $9.81 after the company reported better-than-expected quarterly financial results.
  • Nomura Holdings, Inc. (NYSE: NMR) rose 12.2% to $5.84 following third-quarter results.
  • Paramount Global (NASDAQ: PARA) gained 10.4% to $15.10. Byron Allen offered $14.3 billion to buy all of the outstanding shares of Paramount Global, Bloomberg reported.
  • Revelation Biosciences, Inc. (NASDAQ: REVB) gained 10.3% to $8.77 after dipping around 39% on Tuesday.
  • Nyxoah S.A. (NASDAQ: NYXH) shares rose 9.1% to $8.88 after dipping 34% on Tuesday.
  • Stryker Corporation (NYSE: SYK) gained 5.8% to $335.28 after the company reported better-than-expected fourth-quarter financial results.
Losers
  • Nuvve Holding Corp. (NASDAQ: NVVE) shares dipped 65.8% to $1.1401. Nuvve announced pricing of $9.6 million underwritten public offering of 4.8 million shares of common stock at $2.00 per share.
  • Remark Holdings, Inc. (NASDAQ: MARK) shares fell 36% to $0.80. Remark Holdings shares jumped 264% on Tuesday following a Tweet from the company's X account suggesting an unconfirmed deal with Microsoft..
  • New York Community Bancorp, Inc. (NYSE: NYCB) fell 34.5% to $6.80 after the company reported worse-than-expected fourth-quarter financial results and reduced its quarterly dividend.
  • GRI Bio, Inc. (NASDAQ: GRI) fell 28.6% to $2.05.
  • Genprex, Inc. (NASDAQ: GNPX) declined 28% to $0.1931. Genprex announced a 1-for-40 reverse stock split effective Feb. 2, 2024.
  • Evaxion Biotech A/S (NASDAQ: EVAX) fell 24% to $4.3999.
  • TuSimple Holdings Inc. (NASDAQ: TSP) declined 23.4% to $0.2220.
  • Rail Vision Ltd. (NASDAQ: RVSN) fell 21.9% to $11.70.
  • American Superconductor Corporation (NASDAQ: AMSC) shares declined 18.2% to $0.20 after the company announced a proposed public offering of common stock.
  • Extreme Networks, Inc. (NASDAQ: EXTR) fell 15.8% to $14.02 after the company reported mixed second-quarter financial results and issued guidance.
  • Rockwell Automation, Inc. (NYSE: ROK) declined 15.3% to $260.07 following weak earnings.
  • SMX (Security Matters) Public Limited Company (NASDAQ: SMX) shares fell 14.2% to $0.4067 after jumping 47% on Tuesday.
  • Synaptogenix, Inc. (NASDAQ: SNPX) fell 13% to $0.1864 after gaining 12% on Tuesday.
  • LSB Industries, Inc. (NYSE: LXU) fell 9.5% to $7.51. UBS analyst Joshua Spector downgraded LSB Industries from Buy to Neutral and lowered the price target from $11 to $9.
  • MarketAxess Holdings Inc. (NASDAQ: MKTX) fell 8.8% to $250.01 following weak sales.
  • Teradyne, Inc. (NASDAQ: TER) shares declined 8.2% to $95.99 after the company posted downbeat fourth-quarter sales and issued weak forecast for the first quarter.
  • Oblong, Inc. (NASDAQ: OBLG) declined 8.1% to $0.20 trading after gaining around 24% on Tuesday.
  • Solid Biosciences Inc. (NASDAQ: SLDB) fell 7.5% to $7.47.
  • Alphabet Inc. (NASDAQ: GOOG) (NASDAQ: GOOGL) shares fell 6.2% to $143.60. Alphabet posted better-than-expected earnings results for its fourth quarter on Tuesday. However, Google’s advertising sales came in short of market estimates.
  • Heartland Financial USA, Inc. (NASDAQ: HTLF) fell 5.5% to $36.54.
  • Group 1 Automotive, Inc. (NYSE: GPI) fell 5.5% to $266.64 after the company reported mixed fourth-quarter financial results.
  • Novartis AG (NYSE: NVS) fell around 3% to $104.69 following weak quarterly results.

Now Read This: Bitcoin Falls Below $43,000 Following ADP Report; Blur, Manta Network Among Top Losers

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.